Molecular Therapy: Nucleic Acids (Sep 2019)

PPAR Gamma-Regulated MicroRNA 199a-5p Underlies Bone Marrow Adiposity in Aplastic Anemia

  • Xianning Zhang,
  • Lulu Liu,
  • Cuiyun Dou,
  • Panpan Cheng,
  • Lei Liu,
  • Haihui Liu,
  • Saisai Ren,
  • Cuiling Wang,
  • Shu Jia,
  • Lulu Chen,
  • Hao Zhang,
  • Mingtai Chen

Journal volume & issue
Vol. 17
pp. 678 – 687

Abstract

Read online

Increased propensity of bone marrow-derived mesenchymal stem cells (BM-MSCs) toward adipogenic differentiation has been implicated in the fatty bone marrow and defective hematopoiesis of aplastic anemia (AA). However, the underlying molecular mechanism remains to be investigated. In this study, we found that microRNA 199a-5p (miR-199a-5p) exhibits significantly higher expression in AA BM-MSCs compared with the normal control and is demonstrated to facilitate adipogenic differentiation of BM-MSCs through lentivirus-mediated miR-199a overexpression. Mechanistic investigation reveals that miR-199a-5p could be regulated by PPAR gamma (PPARγ) in a transcription-independent manner and regulates adipogenic differentiation by targeting the expression of transforming growth factor beta induced (TGFBI), which is subsequently validated as a negative regulator of adipogenesis. Besides, the positive correlation between PPARγ and miR-199a-5p expression as well as the inverse relationship between miR-199a-5p and TGFBI expression in normal and AA BM-MSCs was observed. Altogether, our work demonstrates that PPARγ-regulated miR-199a-5p promotes adipogenesis of BM-MSCs by inhibiting TGFBI expression, which might be a novel mechanism underlying the bone marrow adiposity in AA, and provides promising therapeutic targets for AA treatment. Keywords: Aplastic anemia, BM-MSCs, PPARγ, miR-199a-5p, TGFBI